• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

CDC campaign uses testimonials to fight prescription opioid epidemic

September 25, 2017 By Sarah Faulkner

CDCThe Centers for Disease Control and Prevention today launched a campaign featuring real-life stories of people recovering from opioid-use disorder and people whose loved ones have died due to a prescription opioid overdose.

The campaign was designed to boost awareness among Americans about the risks linked with prescription opioids. 91 people die everyday in the U.S. from an opioid-related overdose, according to the CDC.

“The U.S. Dept. of Health and Human Services is committed to using evidence-based methods to communicate targeted messages about the opioid crisis and prevent addiction and misuse in every way we can,” HHS Secretary Dr. Tom Price said in prepared remarks.

“Prevention is a key piece of the five-point strategy HHS unveiled under the Trump Administration for combating this crisis, which has left no corner of America untouched.”

The awareness campaign sports the tagline ‘It only takes a little to lose a lot,’ and includes ads that will run for 14 weeks in Ohio, Kentucky, Massachusetts and New Mexico.

“This campaign is part of CDC’s continued support for states on the frontlines of the opioid overdose epidemic,” CDC director Dr. Brenda Fitzgerald added. “These heartbreaking stories of the devastation brought on by opioid abuse have the potential to open eyes – and save lives.”

The campaign comes after President Donald Trump said he decided to declare the opioid epidemic a national emergency – a plan that has not yet gained any formal momentum.

After Price came forward and said the administration would not make such a move, Trump told reporters that the opioid crisis is an “emergency” and that they would dedicate “a lot of time, a lot of effort and a lot of money on the opioid crisis.”

“It is a serious problem the likes of which we have never had. You know when I was growing up, they had the LSD and they had certain generations of drugs. There’s never been anything like what’s happened to this country over the last four or five years,” the president said. “And I have to say this in all fairness, this is a worldwide problem, not just a United States problem. This is happening worldwide. But this is a national emergency, and we are drawing documents now to so attest.”

Earlier this year, a White House commission responsible for drawing up policy suggestions to curb the opioid crisis released an interim report, writing that declaring a national emergency was the group’s “first and most urgent” recommendation.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Featured, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: Centers for Disease Control & Prevention

IN CASE YOU MISSED IT

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Abbott could pave new roads in diabetes management with dual sensor on the horizon

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS